Nikulski Financial Inc. Sells 9,523 Shares of Lam Research Corporation $LRCX

Nikulski Financial Inc. lowered its stake in Lam Research Corporation (NASDAQ:LRCXFree Report) by 18.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 41,818 shares of the semiconductor company’s stock after selling 9,523 shares during the quarter. Lam Research comprises approximately 1.7% of Nikulski Financial Inc.’s holdings, making the stock its 15th largest holding. Nikulski Financial Inc.’s holdings in Lam Research were worth $7,161,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in LRCX. PMV Capital Advisers LLC bought a new stake in Lam Research in the fourth quarter valued at about $25,000. Stance Capital LLC acquired a new position in Lam Research in the third quarter valued at about $26,000. Howard Hughes Medical Institute bought a new position in Lam Research during the second quarter worth about $27,000. Triumph Capital Management bought a new position in Lam Research during the third quarter worth about $27,000. Finally, Strategic Wealth Investment Group LLC acquired a new position in shares of Lam Research during the 2nd quarter worth about $29,000. 84.61% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Ava Harter sold 1,500 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total value of $333,990.00. Following the completion of the transaction, the insider owned 53,205 shares of the company’s stock, valued at approximately $11,846,625.30. This trade represents a 2.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of Lam Research stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the sale, the chief financial officer owned 1,081,705 shares in the company, valued at $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 130,886 shares of company stock worth $29,658,802 over the last ninety days. Insiders own 0.31% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Argus upped their price target on Lam Research from $175.00 to $280.00 in a research note on Tuesday, February 3rd. Needham & Company LLC boosted their price objective on shares of Lam Research from $250.00 to $300.00 and gave the company a “buy” rating in a report on Thursday, January 29th. Bank of America upped their target price on shares of Lam Research from $195.00 to $245.00 and gave the company a “buy” rating in a research note on Tuesday, January 13th. Weiss Ratings reiterated a “buy (b)” rating on shares of Lam Research in a report on Monday, December 29th. Finally, KeyCorp reissued a “sector weight” rating on shares of Lam Research in a research report on Thursday, January 29th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $245.35.

Read Our Latest Stock Report on LRCX

Lam Research Stock Performance

Shares of Lam Research stock opened at $213.66 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. The firm has a market cap of $266.81 billion, a price-to-earnings ratio of 43.78, a price-to-earnings-growth ratio of 2.15 and a beta of 1.77. The stock’s 50-day moving average is $227.18 and its 200-day moving average is $183.68. Lam Research Corporation has a one year low of $56.32 and a one year high of $256.68.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.10. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The business had revenue of $5.34 billion during the quarter, compared to the consensus estimate of $5.23 billion. During the same period last year, the company earned $0.91 earnings per share. Lam Research’s quarterly revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Equities analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Stockholders of record on Wednesday, March 4th will be issued a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a dividend yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is 21.31%.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.